Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA071618-01
Application #
2010105
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1996-09-13
Project End
2000-06-30
Budget Start
1996-09-13
Budget End
1997-06-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Gao, Boning; Xie, Xian-Jin; Huang, Chunxian et al. (2008) RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 68:22-5
Castro-Rivera, Emely; Ran, Sophia; Brekken, Rolf A et al. (2008) Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res 68:8295-303
Whitehurst, Angelique W; Ram, Rosalyn; Shivakumar, Latha et al. (2008) The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells. Mol Cell Biol 28:3190-7
Ohtani, Shoichiro; Iwamaru, Arifumi; Deng, Wuguo et al. (2007) Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagy. Cancer Res 67:6293-303
Deng, Wu-Guo; Kawashima, Hiroyaki; Wu, Guanglin et al. (2007) Synergistic tumor suppression by coexpression of FUS1 and p53 is associated with down-regulation of murine double minute-2 and activation of the apoptotic protease-activating factor 1-dependent apoptotic pathway in human non-small cell lung cancer cells. Cancer Res 67:709-17
Jayachandran, Gitanjali; Sazaki, Ji-ichiro; Nishizaki, Masahito et al. (2007) Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch. Cancer Res 67:10379-88
Sato, Mitsuo; Vaughan, Melville B; Girard, Luc et al. (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66:2116-28
Moshnikova, Anna; Frye, Judson; Shay, Jerry W et al. (2006) The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. J Biol Chem 281:8143-52
Ueda, Kentaro; Kawashima, Hiroyuki; Ohtani, Shoichiro et al. (2006) The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cells. Cancer Res 66:9682-90
Kim, Y H; Girard, L; Giacomini, C P et al. (2006) Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25:130-8

Showing the most recent 10 out of 54 publications